Press Releases :: iBio Inc. (IBIO)

Skip to main content Skip to section navigation Skip to footer

Year

Category

Sep 30, 2015 8:31 am EDT

New Chinese iBioModulator(TM) Patent Joins iBio Vaccine Portfolio

Sep 21, 2015 8:31 am EDT

iBio Anti-Fibrosis Portfolio Expanded to Include Orally Delivered Peptides

Sep 9, 2015 8:31 am EDT

iBio Fibrosis Therapeutics Program Receives NIH Grant Support

Aug 11, 2015 8:31 am EDT

iBio to Receive US Patent for Influenza Therapeutic

Jun 8, 2015 8:31 am EDT

Three Recent iBioLaunch(TM) Platform Achievements to Be Presented at PBVAB 2015 Conference in Lausanne, Switzerland

May 4, 2015 8:31 am EDT

Vaccine Improvement Patent Awarded to iBio

Apr 27, 2015 8:31 am EDT

iBio Arranges Production of IBIO-CFB03 for Clinical Development With Caliber Biotherapeutics

Mar 30, 2015 8:31 am EDT

iBio European Plague Vaccine Patent Emerges From Opposition Period

Feb 25, 2015 8:31 am EST

iBio Adds Anthrax Antibodies to Product Pipeline

Feb 12, 2015 8:31 am EST

iBio Receives US and European Patents for Protein Expression Technology